Standout Papers

MSC-Based Product Characterization for Clinical Trials: An FDA Perspective 2014 2026 2018 2022 362
  1. MSC-Based Product Characterization for Clinical Trials: An FDA Perspective (2014)
    Michael Mendicino, Alexander M. Bailey et al. Cell stem cell

Immediate Impact

6 from Science/Nature 55 standout
Sub-graph 1 of 23

Citing Papers

LNP-RNA-engineered adipose stem cells for accelerated diabetic wound healing
2024 Standout
Theranostic Fluorescent Probes
2024 Standout
1 intermediate paper

Works of Alexander M. Bailey being referenced

MSC-Based Product Characterization for Clinical Trials: An FDA Perspective
2014 Standout
IFATS Collection: The Role of Human Adipose-Derived Stromal Cells in Inflammatory Microvascular Remodeling and Evidence of a Perivascular Phenotype
2008

Author Peers

Author Last Decade Papers Cites
Alexander M. Bailey 491 452 305 15 1.1k
Thomas Walenda 399 688 278 15 1.1k
Anthony S. Perry 614 601 381 14 1.4k
Lynda O’Rear 587 400 289 22 1.4k
Maria Grazia Iachininoto 636 446 336 21 1.1k
Federica Servida 710 512 237 17 1.3k
Hana Haleem‐Smith 459 345 508 18 1.4k
Sandra Cid 499 547 290 13 1.2k
Tim Brazelton 472 317 450 15 1.0k
Satomi Ando 340 541 191 14 1.2k
Felicia Ng 424 304 195 14 1.0k

All Works

Loading papers...

Rankless by CCL
2026